The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world survival comparison of second-line treatment strategies for patients with RAS/RAF wild-type, right-sided metastatic colorectal cancer.
 
Nishwant Swami
No Relationships to Disclose
 
Wei-Ting Hwang
Employment - Johnson & Johnson innovative medicine (I)
Stock and Other Ownership Interests - Johnson & Johnson innovative medicine (I)
Research Funding - Novartis
 
Ronac Mamtani
Honoraria - Flatiron Health
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Genentech/Roche; Merck; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Merck
Expert Testimony - King and Spalding LLP; McBrayer Firm
 
Mark O'Hara
Consulting or Advisory Role - Alligator Bioscience; Geneos; Natera; Ono Pharmaceutical; PsiOxus Therapeutics; Strike Bio
Research Funding - Arcus Biosciences (Inst); Bristol Myers Squibb Foundation (Inst); Celldex (Inst); Genmab (Inst); HiberCell (Inst); Lilly (Inst); Natera (Inst); Parker Institute for Cancer Immunotherapy (Inst); PsiOxus Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
William Chapin
Travel, Accommodations, Expenses - DAVA Oncology